Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | Cardiff and Vale University Health Board |
| Main Category: | Goods |
| Procurement Method: | Direct award |
| Method Rationale: | This procurement is justified under single supplier grounds due to both exclusive rights and technical reasons. Illumina is the sole provider of the required array platform and associated software, which are protected by intellectual property and cannot be legally or technically replicated by alternative suppliers. The platform is uniquely validated for both germline and acquired copy number analysis across multiple sample types, and its integration with existing workflows and clinical protocols makes substitution technically unfeasible. Additionally, Illumina is the only supplier able to offer the required reagent rental model, including a loaned scanner with full maintenance and replacement guarantees, ensuring continuity of service without additional cost. |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 1 December 2025 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-05acd5 |
| Notice Reference: | 078491-2025 |
All 2 notices for this procurement, oldest first.
Single Nucleotide polymorphism (SNP) ARRAY and reagents platform
Single Nucleotide polymorphism (SNP) ARRAY and reagents platform
View Original Notice
Access the full notice on the official portal
Awarded to
| Award status: | Active |
The All Wales Medical Genomics Service (AWMGS), hosted by Cardiff and Vale University Health Board at the University Hospital of Wales, intends to award a contract for the provision of a single array platform to support both germline and acquired copy number analysis. The platform must be compatible with DNA extracted from a variety of sample types, including blood, amniotic fluid, bone marrow, and other tissues, and demonstrate proven clinical utility across these applications.Due to the current scanning equipment nearing end-of-life and the absence of capital funding, the contract will include the provision of a loaned scanner for the full duration of the agreement, supplied under a reagent rental or similar arrangement. The supplier will retain ownership of the scanner and will be responsible for its maintenance and support throughout the contract term, at no additional cost.The successful supplier, Illumina, will provide all necessary software free of charge, ensure continuity of service by supplying a replacement scanner of identical specification if required, and cover all associated maintenance and support costs
Published contracts in the last 12 months
10
total contracts
£131.3m
total value
£43,753,333
average contract size
Typical categories